🔓
Sign in as a Member to unlock the full view of NVAX. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
GovGreed
NVAX

Novavax, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $1.49B

Novavax is a biotechnology company developing vaccines, with its primary political signal being exposure to 8 healthcare bills with an estimated revenue impact of $16.2M each.

Govt Dependence
10/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat NVAX does

Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its revenue is primarily derived from its protein-based COVID-19 vaccine and its pipeline of vaccine candidates for influenza and other respiratory viruses.

Lifetime Government AwardsNVAX federal contracts

NVAX doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Congressional TradesWho in Congress is trading NVAX

2020-10-13 (unknown) sale $1,001 - $15,000
2020-10-13 (unknown) Sale (Full) $1,001 - $15,000
2020-08-17 (unknown) Purchase $1,001 - $15,000
2020-08-17 (unknown) purchase $1,001 - $15,000
4+ trades on file · most recent 2020-11-05

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

1
option exercises · —
For NVAX, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting NVAXLive legislation impacting this stock

Political ProfileWhere NVAX sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) due to 8 impactful healthcare bills. EVIDENTIARY: No direct political engagement: $0 lobbying (`get_political_influence.lobbying.total_income`), 0 insider buys (`get_corporate_insider_signal.total_buys`), 0 congressional trades (`Top congressional traders`). Net: Pure legislative exposure without supporting political capital.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • High exposure to legislative changes in the healthcare sector.
    U.S. Congress
    "`Recent bill_impacts` lists 8 healthcare bills with material estimated revenue impacts."

Regulatory opportunities

  • Potential revenue upside from favorable healthcare legislation.
    U.S. Congress
    "`Recent bill_impacts` shows multiple bills with positive estimated revenue impacts, indicating legislative tailwinds."
Member intelligence layer

Live signals + predictions for NVAX — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout NVAX & political exposure

Does Novavax, Inc. (NVAX) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Novavax, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded NVAX stock?
4 congressional trades by 1 unique members of Congress, most recently on 2020-10-13. See the Congressional Trading panel for politician-by-politician breakdown.
What is NVAX political risk profile?
Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track NVAX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. NVAX data is updated daily from these official federal sources.